Biotech by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Scholar Rock Holding leads the 24 biotech ranked by short interest, at 19.2%, ahead of CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Scholar Rock Holding19.2%
Median
9.33%
Combined market value
NOK 8.13T
Countries
5

Market values as of .

Biotech by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Scholar Rock HoldingSRRK · Health Care19.2%NOK 55.6BNOK 455.41 4.11% up 14% up United States
2CRISPR TherapeuticsCRSP · Health Care17.7%NOK 38.6BNOK 398.11 2.19% up 21% down Switzerland
3Twist BioscienceTWST · Health Care14.4%NOK 75BNOK 1,099.83 1.21% up 340% up United States
4Kodiak SciencesKOD · Health Care12.4%NOK 61.4BNOK 938.27 0.10% down 396% up United States
5Halozyme TherapeuticsHALO · Health Care12.0%NOK 106.6BNOK 935.27 0.44% up 37% up United States
6ImmunityBioIBRX · Health Care11.9%NOK 68.6BNOK 64.48 6.16% up 193% up United States
7RepligenRGEN · Health Care11.0%NOK 105.3BNOK 1,647.61 4.70% up 5% up United States
8ExelixisEXEL · Health Care10.5%NOK 162.1BNOK 664.17 0.07% down 63% up United States
9CG OncologyCGON · Health Care10.3%NOK 69BNOK 772.93 0.91% up 85% up United States
10Krystal BiotechKRYS · Health Care10.3%NOK 87.4BNOK 2,948.53 1.79% up 46% up United States
11Kymera TherapeuticsKYMR · Health Care9.84%NOK 100.3BNOK 1,174.30 0.41% down 87% up United States
12VaxcytePCVX · Health Care9.70%NOK 88.6BNOK 559.76 2.88% down 22% up United States
13ImmunovantIMVT · Health Care8.96%NOK 67.4BNOK 325.49 1.01% up 43% up United States
14ModernaMRNA · Health Care8.20%NOK 789.9BNOK 1,952.23 2.71% down 755% up United States
15Adaptive BiotechnologiesADPT · Health Care7.09%NOK 44.7BNOK 275.95 0.18% down 88% up United States
16Revolution MedicinesRVMD · Health Care6.05%NOK 333.2BNOK 1,540.54 2.41% down 131% up United States
17Neurocrine BiosciencesNBIX · Health Care5.83%NOK 158.7BNOK 1,567.80 2.62% down 20% up United States
18Bio-TechneTECH · Health Care4.90%NOK 110.8BNOK 705.50 0.11% up 26% up United States
19BiogenBIIB · Health Care3.69%NOK 356.1BNOK 2,409.00 1.00% down 49% up United States
20QiagenQGEN · Health Care3.10%NOK 99.3BNOK 480.73 0.41% down 12% up Netherlands
21AmgenAMGN · Health Care2.33%NOK 2.34TNOK 4,329.74 2.55% down 34% up United States
22argenxARGX · Health Care2.25%NOK 579.6BNOK 9,216.19 0.24% up 4% up Belgium
23Gilead SciencesGILD · Health Care1.72%NOK 2.02TNOK 1,632.62 1.17% down 33% up United States
24BioNTechBNTX · Health Care0.91%NOK 201.8BNOK 813.88 1.15% down 16% down Germany

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7029 NOK).

Questions and answers

Which biotech rank first by short interest?

Scholar Rock Holding (19.2%), CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%) are the top three of the 24 biotech ranked by short interest as of the 30 Oct 2026 settlement date.

How many biotech are in this ranking?

24 are ranked by short interest.

What are these biotech worth together?

The 24 biotech ranked by short interest have a combined market value of NOK 8.13T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Biotech by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.